HC Wainwright & Co. Maintains Buy on Annexon, Raises Price Target to $25
10/19/2026
Impact: 75
Healthcare
HC Wainwright & Co. analyst Ananda Ghosh has maintained a Buy rating on Annexon (NASDAQ: ANNX) and raised the price target from $14 to $25. This adjustment reflects a positive outlook for the company's stock performance.
AI summary, not financial advice
Share: